Boston Scientific
BSX
BSX
669 hedge funds and large institutions have $41.7B invested in Boston Scientific in 2018 Q2 according to their latest regulatory filings, with 96 funds opening new positions, 224 increasing their positions, 225 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
6% more funds holding
Funds holding: 631 → 669 (+38)
1.39% more ownership
Funds ownership: 91.23% → 92.62% (+1.4%)
0% less repeat investments, than reductions
Existing positions increased: 224 | Existing positions reduced: 225
Holders
669
Holding in Top 10
15
Calls
$235M
Puts
$136M
Top Buyers
| 1 | +$481M | |
| 2 | +$153M | |
| 3 | +$131M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$111M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$109M |
Top Sellers
| 1 | -$242M | |
| 2 | -$148M | |
| 3 | -$142M | |
| 4 |
D.E. Shaw & Co
New York
|
-$114M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$84M |